Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gish Biomedical was a medical device company that specialized in the development and manufacture of products for cardiovascular surgery, oncology, and orthopedics. The company was best known for its perfusion products used during open-heart surgery, including blood oxygenators, reservoirs, and filters. Additionally, Gish produced vascular access ports for chemotherapy and specialized surgical suction systems. In 2003, the company was acquired by Sorin Group, which later merged with Cyberonics to form LivaNova. Gish's technologies were integrated into Sorin's broader cardiac surgery portfolio, enhancing their offerings in the extracorporeal circulation market. The company was headquartered in Irvine, California, and was previously traded on the NASDAQ exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gish Biomedical.